Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system combines ...
Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities Visit Vektor Medical at Booth 208 to ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...
First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheter Highly anticipated by electrophysiologists for its innovation and demonstrated safety and ...
SAN FRANCISCO, CA — Add-on ablation for pulmonary-vein isolation (PVI) in patients already undergoing standard isthmus ablation for clinical atrial flutter (AFL) was followed by a steep drop in risk ...
NATICK, Mass., Boston Scientific Corporation completed a first-in-human clinical trial utilizing the IntellaTip MiFi™ XP Ablation Catheter for the treatment of type 1 atrial flutter, an arrhythmia ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — A novel mapping system to identify drivers of atrial fibrillation beyond the pulmonary vein was ...
Atrial flutter is an abnormal heart rhythm where the upper heart chambers beat too fast, reducing the heart’s ability to pump blood effectively and potentially leading to heart muscle damage, stroke, ...
BOSTON--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results